Phibro Animal Health
PAHC
141 hedge funds and large institutions have $337M invested in Phibro Animal Health in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 58 reducing their positions, and 17 closing their positions.
1,214% more call options, than puts
Call options by funds: $92K | Put options by funds: $7K
28% more capital invested
Capital invested by funds: $264M → $337M (+$73.6M)
24% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 17
2% more funds holding
Funds holding: 138 → 141 (+3)
1.34% less ownership
Funds ownership: 100.25% → 98.91% (-1.3%)
22% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 58
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$3.81M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$3.04M |
| 3 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$2.76M |
| 4 |
CM
CastleKnight Management
New York
|
+$2.45M |
| 5 |
Barclays
London,
United Kingdom
|
+$1.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$2.7M |
| 2 |
Pzena Investment Management
New York
|
-$2.11M |
| 3 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
-$1.84M |
| 4 |
BCC
Bridge City Capital
Lake Oswego,
Oregon
|
-$1.78M |
| 5 |
BlackRock
New York
|
-$1.61M |
PAHC Hedge Fund Activity: Q2 2024 in Review
141 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q2 2024, worth a combined $337M — up 28% from $264M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new PAHC positions and 17 closed out — a net gain of 4 holders — while 45 added to existing stakes and 58 trimmed.
The largest buyer was Sofinnova Investments, opening a new position worth an estimated $3.81M. The largest seller was Hotchkis & Wiley Capital Management, cutting an estimated $2.7M.
- 141 institutional investors held Phibro Animal Health (PAHC) as of Q2 2024, up from 138 in Q1 2024.
- Funds reported $337M of Phibro Animal Health stock for Q2 2024, up 28% quarter-over-quarter.
- 21 funds opened new Phibro Animal Health positions in Q2 2024 and 17 closed out, a net change of +4 holders.
- The largest Phibro Animal Health buyer in Q2 2024 was Sofinnova Investments, an estimated $3.81M added.
- The largest Phibro Animal Health seller in Q2 2024 was Hotchkis & Wiley Capital Management, an estimated $2.7M sold.
Based on aggregated 13F filings for Q2 2024.